NR

Nirmalkumar Rameshbhai Patel

Active Director Director DIN 11105752
DIN 11105752 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nirmalkumar Rameshbhai Patel

Data last updated:

Nirmalkumar Rameshbhai Patel is a Director at Vedrishi Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11105752
Primary Designation Director
Industry Healthcare
First Appointment 14 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vedrishi Healthcare Private Limited U21003GJ2025PTC162911
Director14 May 20252025Active

Board colleagues of Nirmalkumar Rameshbhai Patel

Directorship timeline

Open interactive timeline →
Vedrishi Healthcare Private Limited
Premium access

Shareholding and investment profile for Nirmalkumar Rameshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirmalkumar Rameshbhai Patel

Nirmalkumar Rameshbhai Patel currently holds 1 directorship: Vedrishi Healthcare Private Limited (Director, since 14 May 2025).

Nirmalkumar Rameshbhai Patel was first appointed on 14 May 2025 as Director at Vedrishi Healthcare Private Limited.

The current boards of Nirmalkumar Rameshbhai Patel's companies include Dilipkumar Rameshbhai Parmar (Vedrishi Healthcare Private Limited), Pravinbhai Sajjanbhai Prajapati (Vedrishi Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available